160 related articles for article (PubMed ID: 8576800)
1. Extensive esophageal candidiasis in the absence of oral lesions in pediatric AIDS.
Braegger CP; Albisetti M; Nadal D
J Pediatr Gastroenterol Nutr; 1995 Jul; 21(1):104-6. PubMed ID: 8576800
[No Abstract] [Full Text] [Related]
2. Resistance to fluconazole and amphotericin B in a patient with AIDS who was being treated for candidal esophagitis.
Le TP; Tuazon CU; Levine M; Borum M; Rollhauser C
Clin Infect Dis; 1996 Sep; 23(3):649-50. PubMed ID: 8879803
[No Abstract] [Full Text] [Related]
3. Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
Barbaro G; Barbarini G; Di Lorenzo G
Endoscopy; 1995 Jun; 27(5):377-83. PubMed ID: 7588352
[TBL] [Abstract][Full Text] [Related]
4. Outpatient therapy of HIV-associated oral and oesophageal candidosis.
Ustianowski AP; Leake H; Evans S
Int J STD AIDS; 1997 Sep; 8(9):592-4. PubMed ID: 9292351
[No Abstract] [Full Text] [Related]
5. Candida esophagitis complicated by esophageal stricture.
Hyun JJ; Chun HJ; Keum B; Seo YS; Kim YS; Jeen YT; Lee HS; Um SH; Kim CD; Ryu HS
Endoscopy; 2010; 42 Suppl 2():E180-1. PubMed ID: 20640980
[No Abstract] [Full Text] [Related]
6. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
[TBL] [Abstract][Full Text] [Related]
7. Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
Barbaro G; Barbarini G; Di Lorenzo G
Chest; 1996 Dec; 110(6):1507-14. PubMed ID: 8989069
[TBL] [Abstract][Full Text] [Related]
8. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C
Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371
[TBL] [Abstract][Full Text] [Related]
9. [Esophagitis caused by Candida albicans].
Riestra Menéndez S; Sleiman Halabi H; Suárez González A; Rodrigo Sáez L
Rev Esp Enferm Apar Dig; 1989 Aug; 76(2):188-93. PubMed ID: 2682835
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of the therapy of Candida esophagitis in HIV-1-infected patients with fluconazole or amphotericin B and flucytosine].
Brockmeyer NH; Hantschke D; Olbricht T; Hengge UA; Goos M
Mycoses; 1991; 34 Suppl 1():83-6. PubMed ID: 1818270
[TBL] [Abstract][Full Text] [Related]
11. A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis.
Villanueva A; Gotuzzo E; Arathoon EG; Noriega LM; Kartsonis NA; Lupinacci RJ; Smietana JM; DiNubile MJ; Sable CA
Am J Med; 2002 Sep; 113(4):294-9. PubMed ID: 12361815
[TBL] [Abstract][Full Text] [Related]
12. Caspofungin versus amphotericin B for the treatment of Candidal esophagitis.
Chocarro Martínez A; Gonzalez A; Garcia I
Clin Infect Dis; 2002 Jul; 35(1):107; author reply 107-8. PubMed ID: 12060888
[No Abstract] [Full Text] [Related]
13. Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Barbaro G; Barbarini G; Di Lorenzo G
Scand J Infect Dis; 1995; 27(6):613-7. PubMed ID: 8685642
[TBL] [Abstract][Full Text] [Related]
14. Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Barbaro G; Di Lorenzo G
Ital J Gastroenterol; 1995 May; 27(4):175-80. PubMed ID: 8520033
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis.
Barbaro G; Barbarini G; Calderon W; Grisorio B; Alcini P; Di Lorenzo G
Gastroenterology; 1996 Nov; 111(5):1169-77. PubMed ID: 8898629
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients.
Vazquez JA
HIV Clin Trials; 2000; 1(1):47-59. PubMed ID: 11590489
[TBL] [Abstract][Full Text] [Related]
17. [The therapy of Candida esophagitis in AIDS patients with fluconazole].
Heise W; Arasteh K; L'age M
Mycoses; 1990; 33 Suppl 1():32-6. PubMed ID: 2101862
[TBL] [Abstract][Full Text] [Related]
18. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
19. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
Fichtenbaum CJ; Zackin R; Rajicic N; Powderly WG; Wheat LJ; Zingman BS
AIDS; 2000 May; 14(7):845-52. PubMed ID: 10839593
[TBL] [Abstract][Full Text] [Related]
20. Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.
Vuffray A; Durussel C; Boerlin P; Boerlin-Petzold F; Bille J; Glauser MP; Chave JP
AIDS; 1994 May; 8(5):708-9. PubMed ID: 8060555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
